Pfizer/BioNTech vaccine neutralises U.K. SARS-CoV-2 strain in early study
Pfizer and BioNTech have published early in vitro study data showing that the BNT162b2 COVID-19 vaccine generates antibodies that neutralise
Read morePfizer and BioNTech have published early in vitro study data showing that the BNT162b2 COVID-19 vaccine generates antibodies that neutralise
Read moreThe United States FDA has approved the emergency use of Pfizer and BioNTech’s COVID-19 vaccine on Friday, paving the way
Read moreThe UK has become the first western country to approve Pfizer and BioNTech’s COVID-19 vaccine for emergency use. The United
Read moreBioNTech and InstaDeep have entered into an agreement to establish a joint AI Innovation Lab in London, United Kingdom and
Read moreGovernments around the world are scrambling to prepare for the rollout of the Pfizer and BioNTech COVID-19 vaccine, with many
Read morePfizer and BioNTech announced this week that they have reached an agreement with the European Commission to supply 200 million
Read morePfizer and BioNTech have announced their mRNA-based vaccine candidate for COVID-19, tested in a Phase 3 study involving 43,538 participants,
Read moreNext-gen immunotherapy company BioNTech announced this month the completion of a share purchase agreement with Swiss pharma giant Novartis AG,
Read moreThe United Kingdom has signed and finalised the negotiations for the procurement of 90 million doses of vaccines in development
Read more